<i>Ginkgo biloba</i> Extract Prescriptions Are Associated with Slower Progression of Dementia Severity—Analysis of Longitudinal Real-World Data
Background/Objectives: Previous research indicates that <i>Ginkgo biloba</i> extract (Gbe) may contribute to slowing down the progression of dementia. This retrospective cohort study analyzed the association between Gbe prescriptions and the progression of dementia severity in a real-wor...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Brain Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3425/15/1/12 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832588903773634560 |
|---|---|
| author | Jens Bohlken André Hajek Martin Burkart Karel Kostev |
| author_facet | Jens Bohlken André Hajek Martin Burkart Karel Kostev |
| author_sort | Jens Bohlken |
| collection | DOAJ |
| description | Background/Objectives: Previous research indicates that <i>Ginkgo biloba</i> extract (Gbe) may contribute to slowing down the progression of dementia. This retrospective cohort study analyzed the association between Gbe prescriptions and the progression of dementia severity in a real-world setting. Methods: This study was conducted using data from patients with an initial diagnosis of mild or moderate dementia between January 2005 and December 2022 from the IQVIA™ Disease Analyzer database. The follow-up period was up to 10 years. The association between Gbe prescription and dementia severity progression was assessed by Kaplan–Meier analysis and Cox regression, with adjustments made for age, sex, health insurance status, physician specialty, co-prescription of antidementia drugs, and co-diagnoses. Results: A total of 4765 patients were included, of whom 177 were prescribed Gbe. The cumulative incidence of dementia severity progression was 12.7% for patients with Gbe prescription and 22.1% for those without. Gbe prescription was associated with a significantly decreased risk of dementia severity progression (hazard ratio: 0.50; 95% CI: 0.27–0.95), both in patients with mild (HR: 0.44; 95% CI: 0.22–0.90) and moderate dementia (HR: 0.24; 95% CI: 0.06–0.98). Conclusions: This study provides evidence that Gbe prescription is associated with a reduced risk of dementia severity progression in a real-world setting. |
| format | Article |
| id | doaj-art-6341ca5e59e64b57a1174c39581f849d |
| institution | Kabale University |
| issn | 2076-3425 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Brain Sciences |
| spelling | doaj-art-6341ca5e59e64b57a1174c39581f849d2025-01-24T13:25:39ZengMDPI AGBrain Sciences2076-34252024-12-011511210.3390/brainsci15010012<i>Ginkgo biloba</i> Extract Prescriptions Are Associated with Slower Progression of Dementia Severity—Analysis of Longitudinal Real-World DataJens Bohlken0André Hajek1Martin Burkart2Karel Kostev3Institute of Social Medicine, Occupational Health and Public Health, Faculty of Medicine, University of Leipzig, 04103 Leipzig, GermanyDepartment of Health Economics and Health Services Research, University Medical Center, 20246 Hamburg, GermanyGlobal Medical Affairs, Dr. Schwabe Holding SE & Co. KG, 76227 Karlsruhe, GermanyEpidemiology, IQVIA, 60549 Frankfurt am Main, GermanyBackground/Objectives: Previous research indicates that <i>Ginkgo biloba</i> extract (Gbe) may contribute to slowing down the progression of dementia. This retrospective cohort study analyzed the association between Gbe prescriptions and the progression of dementia severity in a real-world setting. Methods: This study was conducted using data from patients with an initial diagnosis of mild or moderate dementia between January 2005 and December 2022 from the IQVIA™ Disease Analyzer database. The follow-up period was up to 10 years. The association between Gbe prescription and dementia severity progression was assessed by Kaplan–Meier analysis and Cox regression, with adjustments made for age, sex, health insurance status, physician specialty, co-prescription of antidementia drugs, and co-diagnoses. Results: A total of 4765 patients were included, of whom 177 were prescribed Gbe. The cumulative incidence of dementia severity progression was 12.7% for patients with Gbe prescription and 22.1% for those without. Gbe prescription was associated with a significantly decreased risk of dementia severity progression (hazard ratio: 0.50; 95% CI: 0.27–0.95), both in patients with mild (HR: 0.44; 95% CI: 0.22–0.90) and moderate dementia (HR: 0.24; 95% CI: 0.06–0.98). Conclusions: This study provides evidence that Gbe prescription is associated with a reduced risk of dementia severity progression in a real-world setting.https://www.mdpi.com/2076-3425/15/1/12dementiaAlzheimer’s disease<i>Ginkgo biloba</i> extractcognitive impairmentphytomedicineretrospective study |
| spellingShingle | Jens Bohlken André Hajek Martin Burkart Karel Kostev <i>Ginkgo biloba</i> Extract Prescriptions Are Associated with Slower Progression of Dementia Severity—Analysis of Longitudinal Real-World Data Brain Sciences dementia Alzheimer’s disease <i>Ginkgo biloba</i> extract cognitive impairment phytomedicine retrospective study |
| title | <i>Ginkgo biloba</i> Extract Prescriptions Are Associated with Slower Progression of Dementia Severity—Analysis of Longitudinal Real-World Data |
| title_full | <i>Ginkgo biloba</i> Extract Prescriptions Are Associated with Slower Progression of Dementia Severity—Analysis of Longitudinal Real-World Data |
| title_fullStr | <i>Ginkgo biloba</i> Extract Prescriptions Are Associated with Slower Progression of Dementia Severity—Analysis of Longitudinal Real-World Data |
| title_full_unstemmed | <i>Ginkgo biloba</i> Extract Prescriptions Are Associated with Slower Progression of Dementia Severity—Analysis of Longitudinal Real-World Data |
| title_short | <i>Ginkgo biloba</i> Extract Prescriptions Are Associated with Slower Progression of Dementia Severity—Analysis of Longitudinal Real-World Data |
| title_sort | i ginkgo biloba i extract prescriptions are associated with slower progression of dementia severity analysis of longitudinal real world data |
| topic | dementia Alzheimer’s disease <i>Ginkgo biloba</i> extract cognitive impairment phytomedicine retrospective study |
| url | https://www.mdpi.com/2076-3425/15/1/12 |
| work_keys_str_mv | AT jensbohlken iginkgobilobaiextractprescriptionsareassociatedwithslowerprogressionofdementiaseverityanalysisoflongitudinalrealworlddata AT andrehajek iginkgobilobaiextractprescriptionsareassociatedwithslowerprogressionofdementiaseverityanalysisoflongitudinalrealworlddata AT martinburkart iginkgobilobaiextractprescriptionsareassociatedwithslowerprogressionofdementiaseverityanalysisoflongitudinalrealworlddata AT karelkostev iginkgobilobaiextractprescriptionsareassociatedwithslowerprogressionofdementiaseverityanalysisoflongitudinalrealworlddata |